Article Details

Redosable Gene-Therapy Developer Generation Bio Wins $100M Series B Financing

Retrieved on: 2018-02-26 22:46:01

Tags for this article:

Click the tags to see associated articles and topics

Redosable Gene-Therapy Developer Generation Bio Wins $100M Series B Financing. View article details on hiswai:

Excerpt

<div>Headquartered in Cambridge, MA, Generation Bio was launched less than two months ago by <b>Atlas Venture</b>, which founded the company with a $25 million Series A financing. “Generation Bio is creating a breakthrough category of therapeutics and is positioned to be a leader in the gene therapy field,” ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up